LAMY appoints Stephen Townsend as COO; grants 250,000 shares as compensation

Exousia Bio, Inc.

Stephen Townsend appointed as Chief Operating Officer, effective immediately, until March 2024 annual meeting.
Compensation consists of 250,000 shares of LAMY common stock for 12 months of service.
Townsend brings over 20 years of finance and real estate credit expertise to the role.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Stephen Edward Townsend

Chief Operating Officer

LMMY · Exousia Bio, Inc.

Effective: 2023-03-15
Filed: March 17, 2023, 7:59 PM ET

On March 15, 2023, the board of directors (the “Board”) of LAMY (the “Company”) appointed Mr. Stephen Edward Townsend, to the Board as Chief Operating Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Stephen Edward Townsend was appointed as Chief Operating Officer at Exousia Bio, Inc..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

On March 15, 2023, the board of directors (the “Board”) of LAMY (the “Company”) appointed Mr. Stephen Edward Townsend, to the Board as Chief Operating Officer.

View on SEC.gov

Exousia Bio, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-23-001567

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.